Russ Altman uses computer technology to explore how our genes affect the ways our bodies respond to drugs.

A Stanford professor of bioengineering, genetics and medicine, Altman leads Simbios, an NIH Center for Biomedical Computation, and holds a BA from Harvard College, an MD from Stanford Medical School and a PhD in medical information sciences from Stanford. Altman received the U.S. Presidential Early Career Award for Scientists and Engineers, a National Science Foundation CAREER Award and Stanford Medical Schools graduate teaching award. He chairs the Science Board advising the Food and Drug Administration and is a founder of Personalis Inc.